Fecal Microbiota Transplantation in Crohn's Disease as Relay After Anti-TNF Withdrawal
Recruiting now · Phase 3 · Has a placebo group
Conditions studied: Crohn Disease
In brief
Crohn's disease (CD) is a chronic inflammatory bowel disease. CD pathogenesis remains poorly understood but involves an inappropriate immune response toward an unbalanced gut microbiota in predisposed hosts. The purpose of this study is to evaluate de clinical efficacy of the fecal microbiota transplantation (FMT) as a maintenance treatment following anti-TNF agent withdrawal in CD's patient.
Key facts
- Study ID
- NCT04997733
- Run by
- Assistance Publique - Hôpitaux de Paris
- People needed
- 150
- Starts
- 2021-09-22
- Expected to finish
- 2029-07-22
- Last updated by the study team
- 2025-08-11
Who can join
Age: 18 and older, up to 74. Sex: any. Healthy volunteers: accepted.
Where it is running
- Gastroenterology Department of Saint Antoine Hospital — Paris, France (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.